This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The round will fuel product and growth initiatives to further Bonfire’s mission of accelerating healthtech adoption such that life-saving digital tools, devices, and therapeutics get into the hands of patients faster than ever before. Healthtech is a burgeoning part of the healthcare industry and has rapidly risen in value.
With this acquisition, Gerresheimer strengthens its European footprint with additional production sites and underpins its market position as a leading full-service provider and global partner for the pharma and biotechindustries. Gerresheimer expects the acquisition to be accretive to the Group’s Adj. EBITDA margin and Adj.
DigitalHealth Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings. Another example is CliniScout Recruit by Healthware – a digital service for recruiting subjects to clinical trials.
“Our collaboration with the Association will create valuable opportunities for thousands of members to engage with industry, apply their expertise in new roles, and shape the future of healthcare technology.” MDisrupt has raised $6.6 million to date, including its most recent $3 million in seed funding.
Co-founded by industry leaders Luis Voloch, Mark Jacobstein, and Sahil Sudeach with a background in AI, healthcare, and biotechnologyJimini Health brings together expertise from healthcare and technology to create an evidence-backed, clinician-led mental health model.
Biotech Showcase is true to its name – great companies are highlighted.” Tina Elder, Global Managing Director, EBD Group US, said, “Biotech Showcase has once again shown itself to be the premiere destination for innovators and partners to access a powerful network of industry decision-makers, media and top investors.
Exec Summary: The digitalhealth IPO boom of 2021 saw a surge of companies entering the public market, but the landscape has shifted since then. Why did so many DigitalHealth companies go public in 2021? There were a confluence of factors that fueled the surge of digitalhealth companies going public in 2021: 1.
We can see the Amazon column (second in alpha order following Alibaba) with more checkmarks (in dots) indicating the most health care activities by type compared with any other “tech giant” in the world.
Several consumer surveys published to coincide with CES 2020 provide insights into the new consumer trust mindset across industries, but especially important for health engagement. The DigitalHealth Summit at CES collaborated with Kantar on a poll gauging peoples’ perspectives on trust , technology and health.
Aptar DigitalHealth’s SaMD platform offers digitalhealth solutions adapted to the patient’s profile, disease state and treatment plan to empower them during their treatment journey. CRYSTAL LAKE, Ill.–(BUSINESS
Biotech and software firms are actively investing in AI healthcare platforms capable of symptom assessment, multilingual medical guidance, and automated notetaking. Evolving the DigitalHealth Journey The considerable expense of employee benefits often fails to yield optimal returns. The reason? Underutilization.
The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges.
2018 DigitalHealth Prediction 2: Voice technology will be the first step to personalising pharma. By the end of the year we will see the use of Virtual Assistants by patients to help interact with their health data and "transact" via voice technology to order repeat prescriptions, pain management and medication requests.
BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digitalhealth technology and develop digital biomarkers for Parkinson’s disease.
By working together to streamline this regulatory process, technology will arrive to the market faster and propel the healthcare industry forward. For example, the FDA created a new unit within the agency’s Center for Devices and Radiological Health , which focuses solely on digitalhealth. FDA Shows Signs of Progress.
Big Pharmas looming patent cliffs could drive outlier deals (7-8x or more) for late-stage innovators, especially in biotech-adjacent HealthTech. The higher revenue multiple for HealthTech companies reflects the fact that the healthcare market is growing rapidly and there is a lot of demand for innovative digitalhealth solutions.
Together with our partners from the École Polytechnique Fédérale de Lausanne, the University of Geneva and Geneva University Hospital, the Wyss Center is poised to catalyze the unique concentration of world-class brain health research at Campus Biotech to drive clinical breakthroughs.”
Woman-led biotech company, Sanguina, secures funding to advance accessible digitalhealth and wellness platforms PEACHTREE CORNERS, Ga.–(BUSINESS Sanguina’s flagship product, the AnemoCheck app, is a digitalhealth platform that estimates hemoglobin levels and aids users in managing anemia.
–(BUSINESS WIRE)– #Biotech –Taking a people-first approach, BioscienceLA, the ecosystem accelerator for life sciences in Greater Los Angeles, has launched its inaugural Leadership Catalyst Program for trailblazers in biotechnology and related sectors. We are delighted to be part of this impactful program.”
Technological advancements in biology, AI and automation are transforming the industry, with business models seeing the convergence of traditional players in novel ways. “We are witnessing unprecedented innovation across the healthcare landscape,” said Robert Mittendorff, MD, General Partner and Head of Healthcare at B Capital. .
Digging deeper into some of the big trends, Shelly’s observations will also ring authentic to health/care stakeholders… AI is everywhere at CES. As my friends at #JPM this week are hearing in San Francisco, AI is part of virtually every biotech and med-tech story. As Shelly put it, we in industry have a responsibility.
The same definition of patient engagement applies to industry, except that the interventions lead to more human centered design and value-based care. Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users.
Bonfire Analytics is a company that enables digitalhealth, medical device, and biotech organizations to identify qualified leads through machine learning and analytics. Funding within healthtech can be difficult due to the competitiveness of the industry.
This agreement is set to intensify collaboration and bolster industry growth in of both regions. Fostering global connections and innovation and fueling growth are key to advancing the life sciences industry in Florida,” said Nancy K. Bryan, President & CEO of BioFlorida. Preferential registration rates for all partnered events.
This new fund underscores the firm’s continued commitment to driving innovation and elevating health globally through investments in digitalhealth, medical devices, life sciences, and tech-enabled care delivery. OpenLoop : An end-to-end telemedicine enablement company surpassed $100 million in annualized revenues in early 2024.
The results of this Pew study tell us that consumers’ trust levels if various industry segments are low: especially for pharma, financial services, and marketers. It’s not new-news that consumers’ trust in pharma has eroded for years, as I pointed out here in Health Populi based on the latest Edelman Trust Barometer.
These four pillars Susannah, Lisa and I addressed in the context of PLM+UHG are also raised in today’s deal…with some nuances intriguing me around the public’s trust in the tech industry, as well as the nature and mission of a faith-based healthcare organization. health care. health care.
Claudia Pingue, senior partner and head of the Technology Transfer Fund of CDP Venture Capital SGR , added: “Aptadir is the first biotech company born from EXTEND, National Technology Transfer hub established on the initiative of CDP Venture Capital and funded with co-investment partners, Angelini Ventures and Evotec.
These figures highlight its ability to grow profitably, a rarity in healthcare IT, and its dominance in the digital physician market, which it expects to expand 5-7% annually, with Doximity aiming to outpace that. markets 20.29%, but their 21.78% return on assets beats the industrys 9.29%. Subscribe Today! crushed the $0.34
QuantHealth proudly supports several large pharma companies, numerous biotechs, as well as CROs, and other industry partners. percent in 2022, the lowest the industry has seen in decades,” said Orr Inbar, CEO and Co-Founder of QuantHealth.
Players Include 1DropDiagnostics, Abbott Laboratories, Ador Diagnostics, ADT Biotech and Akonni Biosystems DUBLIN–(BUSINESS WIRE)–The “OTC/DTC Infectious Disease Diagnostics Strategies and Trends for Over the Counter and Direct to Consumer. Industry Participants 4.2 Industry Structure 5 Market Trends 5.1
The healthcare industry is hungry for solutions that combine advanced AI technology with practical applications, said Matt Miller, Managing Partner at Headwater Ventures. With offices in Dallas, Houston, and Austin, GPG Ventures invests nationally in biotech, digitalhealth, medtech, consumer health, and general B2B tech.
While many industries plummeted in the first quarter of the year, digitalhealth companies closed the first quarter of 2020 with unprecedented levels of funding. Private equity and venture capital financing of digitalhealth start-ups reached an all-time high of just over $3 billion in Q1 2020.
Combined, the network helps pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, and solve unique geographic and market-specific challenges. About EVERSANA® EVERSANA® is a leading independent provider of global services to the life sciences industry.
DigitalHealth Solutions: Digitalhealth solutions are gaining traction in wound care, enabling remote monitoring, telemedicine consultations, and data-driven decision-making. Innovative technologies and digitalhealth solutions can help reduce costs and improve efficiency. Subscribe Today!
Exec Summary: The digitalhealth IPO boom of 2021 saw a surge of companies entering the public market, but the landscape has shifted since then. Why did so many DigitalHealth companies go public in 2021? There were a confluence of factors that fueled the surge of digitalhealth companies going public in 2021: 1.
Colin’s track record with global biopharma and biotech partners is extensive and admirable,” added Chris Garabedian, a VivoSense Board Member. “He Colin is a proven leader with a deep understanding of the digitalhealth technology industry. Colin has demonstrated strong leadership to his teams and customers alike.” “I
Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.
–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digitalhealth solutions to better meet the needs of healthcare professionals, regulators and patients. in 2060.
Founded in 2015 and headquartered in New York, m+a offers full-service capabilities to a diverse group of blue-chip pharma, biotech, and digitalhealth companies across a range of therapeutic categories, including rare diseases, mental health, oncology, CNS, dermatology, and more. The Amulet team brings all that and more.
A comprehensive and insightful report analyzing these transformative trends has been added to our industry-leading research publication collections. These technical advancements are analyzed for their potential to change current market paradigms and foster a growing and evolving industry. Industry Participants 4.1.1 Testing 3.6.3
–(BUSINESS WIRE)– Aviceda Therapeutics , a clinical-stage biotech company focused on developing next-generation immuno-modulators to treat diseases such as cancer, today announced a strategic partnership with the Patrick G Johnston Centre for Cancer Research at Queen’s University Belfast (Queen’s). CAMBRIDGE, Mass.–(BUSINESS
The LEARNS study seeks to generate evidence to extend the Koneksa solution to new digital modalities and diseases,” said John Wagner, MD, PhD, Chief Medical Officer, Koneksa. Beacon’s mobile EEG will join more than a dozen digitalhealth technologies that are already integrated into the Koneksa solution.
The company has also partnered with European hospitals and healthcare providers to develop digitalhealth solutions. Tencent Healthcare: the technology company has developed a number of healthtech products, such as a medical image analysis platform and a digitalhealth record system.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
120 
Let's personalize your content